Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial

• Main Authors: Mohammed Fasihul Alam (Author), Mirella Longo (Author), David Cohen (Author), Sam Groves (Author), Laith Alrubaiy (Author), Hayley A. Hutchings (Author), Alan Watkins (Author), Shaji Sebastain (Author), John G. Williams (Author)
• Format: Book
• Published: BMC, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background There is limited evidence in the literature on the long-term effectiveness and cost-effectiveness of treatments for Acute Severe Ulcerative Colitis (ASUC). The study aimed to perform decision analytic model-based long-term cost-utility analysis (CUA) of infliximab versus ciclospo...